These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 14751425)

  • 1. Effects of the vanilloid agonist olvanil and antagonist capsazepine on rat behaviors.
    Kasckow JW; Mulchahey JJ; Geracioti TD
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):291-5. PubMed ID: 14751425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the use-dependent, nicotinic receptor antagonist BTMPS in the forced swim test and elevated plus maze after cocaine discontinuation in rats.
    Hall BJ; Pearson LS; Buccafusco JJ
    Neurosci Lett; 2010 Apr; 474(2):84-7. PubMed ID: 20226229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological characterization of the vanilloid receptor in the rat dorsal spinal cord.
    Wardle KA; Ranson J; Sanger GJ
    Br J Pharmacol; 1997 Jul; 121(5):1012-6. PubMed ID: 9222561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relaxant effect of capsazepine in the isolated rat ileum.
    Nocerino E; Izzo AA; Borrelli F; Capasso F; Capasso R; Pinto A; Sautebin L; Mascolo N
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Mar; 365(3):187-92. PubMed ID: 11882914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of anxiety-like behaviour by Transient Receptor Potential Vanilloid Type 1 (TRPV1) channels located in the dorsolateral periaqueductal gray.
    Terzian AL; Aguiar DC; Guimarães FS; Moreira FA
    Eur Neuropsychopharmacol; 2009 Mar; 19(3):188-95. PubMed ID: 19064314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signaling mechanisms of down-regulation of voltage-activated Ca2+ channels by transient receptor potential vanilloid type 1 stimulation with olvanil in primary sensory neurons.
    Wu ZZ; Chen SR; Pan HL
    Neuroscience; 2006 Aug; 141(1):407-19. PubMed ID: 16678970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GABA and histamine interaction in the basolateral amygdala of rats in the plus-maze test of anxiety-like behaviors.
    Hajizadeh Moghaddam A; Roohbakhsh A; Rostami P; Heidary-Davishani A; Zarrindast MR
    Pharmacology; 2008; 82(1):59-66. PubMed ID: 18477857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-arachidonoyl-serotonin in the basolateral amygdala increases anxiolytic behavior in the elevated plus maze.
    John CS; Currie PJ
    Behav Brain Res; 2012 Aug; 233(2):382-8. PubMed ID: 22633963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Capsaicin-, resiniferatoxin-, and olvanil-induced adrenaline secretions in rats via the vanilloid receptor.
    Watanabe T; Sakurada N; Kobata K
    Biosci Biotechnol Biochem; 2001 Nov; 65(11):2443-7. PubMed ID: 11791717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anxiogenic-like effect induced by TRPV1 receptor activation within the dorsal periaqueductal gray matter in mice.
    Mascarenhas DC; Gomes KS; Nunes-de-Souza RL
    Behav Brain Res; 2013 Aug; 250():308-15. PubMed ID: 23707246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Halogenation of a capsaicin analogue leads to novel vanilloid TRPV1 receptor antagonists.
    Appendino G; Harrison S; De Petrocellis L; Daddario N; Bianchi F; Schiano Moriello A; Trevisani M; Benvenuti F; Geppetti P; Di Marzo V
    Br J Pharmacol; 2003 Aug; 139(8):1417-24. PubMed ID: 12922928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of strain difference in behavior to Cholecystokinin (CCK) receptor mediated drugs in PVG hooded and Sprague-Dawley rats using elevated plus-maze test apparatus.
    Farook JM; Zhu YZ; Wang Q; Moochhala SM; Lee L; Wong PT
    Neurosci Lett; 2004 Apr; 358(3):215-9. PubMed ID: 15039119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuation of anxiety-related behaviour after the antagonism of transient receptor potential vanilloid type 1 channels in the rat ventral hippocampus.
    Santos CJ; Stern CA; Bertoglio LJ
    Behav Pharmacol; 2008 Jul; 19(4):357-60. PubMed ID: 18622185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of apomorphine on rat behavior in the elevated plus-maze.
    Garcia AM; Martinez R; Brandão ML; Morato S
    Physiol Behav; 2005 Jul; 85(4):440-7. PubMed ID: 16002103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The NK1 receptor antagonist NKP608 lacks anxiolytic-like activity in Swiss-Webster mice exposed to the elevated plus-maze.
    Rodgers RJ; Gentsch C; Hoyer D; Bryant E; Green AJ; Kolokotroni KZ; Martin JL
    Behav Brain Res; 2004 Sep; 154(1):183-92. PubMed ID: 15302124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dansyl-PQRamide, a putative antagonist of NPFF receptors, reduces anxiety-like behavior of ethanol withdrawal in a plus-maze test in rats.
    Kotlinska J; Pachuta A; Bochenski M; Silberring J
    Peptides; 2009 Jun; 30(6):1165-72. PubMed ID: 19463751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral effects of the beta3 adrenoceptor agonist SR58611A: is it the putative prototype of a new class of antidepressant/anxiolytic drugs?
    Consoli D; Leggio GM; Mazzola C; Micale V; Drago F
    Eur J Pharmacol; 2007 Nov; 573(1-3):139-47. PubMed ID: 17669397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interplay between glutamate and serotonin within the dorsal periaqueductal gray modulates anxiety-related behavior of rats exposed to the elevated plus-maze.
    Moraes CL; Bertoglio LJ; Carobrez AP
    Behav Brain Res; 2008 Dec; 194(2):181-6. PubMed ID: 18675851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoid CB1 receptors of the rat central amygdala mediate anxiety-like behavior: interaction with the opioid system.
    Zarrindast MR; Sarahroodi S; Arzi A; Khodayar MJ; Taheri-Shalmani S; Rezayof A
    Behav Pharmacol; 2008 Oct; 19(7):716-23. PubMed ID: 18797248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anxiolytic-like activity of the non-selective galanin receptor agonist, galnon.
    Rajarao SJ; Platt B; Sukoff SJ; Lin Q; Bender CN; Nieuwenhuijsen BW; Ring RH; Schechter LE; Rosenzweig-Lipson S; Beyer CE
    Neuropeptides; 2007 Oct; 41(5):307-20. PubMed ID: 17637475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.